Two Natural Cap
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Maravai: Can an mRNA Capping Provider Move Beyond Covid? $mrvi
mRNA, Biologics Safety Testing, and Cell/Gene Therapy
Jul 25
•
Two Natural Capital
2
Share this post
Two Natural Cap
Maravai: Can an mRNA Capping Provider Move Beyond Covid? $mrvi
Copy link
Facebook
Email
Notes
More
June 2025
CAR-T Therapy: How Can CRISPR Help?
Donors Cells, Immune System Evasion, AvenCell/Intellia/CRISPR Therapeutics
Jun 25
•
Two Natural Capital
1
Share this post
Two Natural Cap
CAR-T Therapy: How Can CRISPR Help?
Copy link
Facebook
Email
Notes
More
CRISPR Comes Back to Life
Baby KJ, LNPs, and Danaher
Jun 11
•
Two Natural Capital
1
Share this post
Two Natural Cap
CRISPR Comes Back to Life
Copy link
Facebook
Email
Notes
More
May 2025
Casey’s General Stores: A Dollar General Approach to Gas Stations $casy
Pizza, Buc-ee’s, Expansion, and Zyn
May 7
•
Two Natural Capital
4
Share this post
Two Natural Cap
Casey’s General Stores: A Dollar General Approach to Gas Stations $casy
Copy link
Facebook
Email
Notes
More
April 2025
In Situ Sequencing: 10x Genomics, NanoString, and Vizgen $txg $brkr
Lawsuits, Sensitivity/Specificity, and Mouse Brains
Apr 25
•
Two Natural Capital
2
Share this post
Two Natural Cap
In Situ Sequencing: 10x Genomics, NanoString, and Vizgen $txg $brkr
Copy link
Facebook
Email
Notes
More
Illumina: What Does a Hypothetical Bull Case Look Like? $ilmn
The Single-Cell and Spatial Opportunity
Apr 10
•
Two Natural Capital
7
Share this post
Two Natural Cap
Illumina: What Does a Hypothetical Bull Case Look Like? $ilmn
Copy link
Facebook
Email
Notes
More
3
March 2025
Solid BioSciences, Sarepta, and Regenxbio ($sldb, $srpt, $rgnx)
Gene therapies for the largest gene in the body, protein-protein interaction choices, and the importance of capsid design.
Mar 19
•
Two Natural Capital
Share this post
Two Natural Cap
Solid BioSciences, Sarepta, and Regenxbio ($sldb, $srpt, $rgnx)
Copy link
Facebook
Email
Notes
More
February 2025
Blackstone: A Test in Generating Alpha at Scale $bx
Perpetual Capital, Private Credit, and the Power of a Brand Name
Feb 27
•
Two Natural Capital
2
Share this post
Two Natural Cap
Blackstone: A Test in Generating Alpha at Scale $bx
Copy link
Facebook
Email
Notes
More
January 2025
PacBio $pacb
Long-read vs Short-read, Cancer Testing, and Debt Paydown vs Innovation
Jan 23
•
Two Natural Capital
1
Share this post
Two Natural Cap
PacBio $pacb
Copy link
Facebook
Email
Notes
More
December 2024
Sarepta Therapeutics: From Exon-Skipping to Gene Therapy $srpt
Business model shifts, incentives to innovate, and a flywheel for rare diseases
Dec 12, 2024
•
Two Natural Capital
3
Share this post
Two Natural Cap
Sarepta Therapeutics: From Exon-Skipping to Gene Therapy $srpt
Copy link
Facebook
Email
Notes
More
October 2024
Sophia Genetics: The Benefits/Drawbacks of Sequencer Agnosticism $soph
Akre Capital, Illumina/Ultima/Element, and Data-Driven Healthcare.
Oct 30, 2024
•
Two Natural Capital
5
Share this post
Two Natural Cap
Sophia Genetics: The Benefits/Drawbacks of Sequencer Agnosticism $soph
Copy link
Facebook
Email
Notes
More
4
September 2024
Tempus AI: A (Tentative) Short Thesis $tem
Company name changes, reimbursement decisions, and clinical AI vs GitHub Copilot
Sep 25, 2024
•
Two Natural Capital
8
Share this post
Two Natural Cap
Tempus AI: A (Tentative) Short Thesis $tem
Copy link
Facebook
Email
Notes
More
1
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts